Efficacy profiles for different concentrations of Lactobacillus acidophilus in experimental colitis

doi:10.3748/wjg.v19.i32.5347

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 32

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5994)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series.

Item

Count

PDF

446

HTML

3774

Figures (1-5)

185

Sum=4405

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

811

Download

771

Sum=1582

Aug 28, 2013 (publication date) through Apr 23, 2024

Times Cited of This Article

Times Cited (20)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Aug 28, 2013; 19(32): 5347-5356
Published online Aug 28, 2013. doi: 10.3748/wjg.v19.i32.5347

Efficacy profiles for different concentrations of Lactobacillus acidophilus in experimental colitis

Lin-Lin Chen, Yi-You Zou, Fang-Gen Lu, Fu-Jun Li, Guang-Hui Lian

Lin-Lin Chen, Yi-You Zou, Fu-Jun Li, Guang-Hui Lian, Department of Gastroenterology, Xiangya Hospital of Central South University, Changsha 410008, Hunan Province, China

Fang-Gen Lu, Department of Gastroenterology, Second Xiangya Hospital of Central South University, Changsha 410011, Hunan Province, China

Author contributions: Chen LL performed the experiments; Zou YY and Lu FG designed the study and revised the article for intellectual content; Li FJ and Lian GH analyzed the data, performed statistical analyses and revised the article for intellectual content.

Correspondence to: Lin-Lin Chen, MD, Department of Gastroenterology, Xiangya Hospital of Central South University, Kaifu District, No. 87 Xiangya Road, Changsha 410008, Hunan Province, China. chenlinlinmedical@gmail.com

Telephone: +86-731-84327332 Fax: +86-731-84327332

Received: March 13, 2013
Revised: June 3, 2013
Accepted: July 18, 2013
Published online: August 28, 2013

Core Tip

Core tip: Efficacies of the current treatments for ulcerative colitis (UC) are limited by procedure-related complications, poor patient compliance, and high relapse rates. Administration of supplemental probiotics represents a promising new therapy of UC. Since UC pathogenic sites mainly involve the rectum and colon and UC patients show differential composition profiles of intestinal bacteria, this study was designed to evaluate the therapeutic efficacies of various concentrations for the standard probiotic, Lactobacillus acidophilus, using a well-known murine model of experimental colitis to examine the changes in colitis symptoms and the corresponding effects on the bacterial flora in the distal and proximal colon.